Literature DB >> 19734735

Multiple myeloma and systemic lupus erythematosus in a young woman.

Kelechi Okoli1, Farzan Irani, William Horvath.   

Abstract

Although systemic lupus erythematosus (SLE) is associated with lymphoid malignancies, concurrent multiple myeloma and SLE are rare. We report a 28-year-old black woman with SLE who developed smoldering IgA kappa multiple myeloma. The coexistence of these conditions in this age and race has not been previously reported. A literature search was conducted and all 12 previously reported cases of concurrent SLE and multiple myeloma were reviewed. The demographic and clinical features of multiple myeloma in SLE are summarized. Possible mechanisms underlying this association are also discussed. In the appropriate clinical context, multiple myeloma should be considered in SLE patients irrespective of young age, race, SLE disease activity, or duration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19734735     DOI: 10.1097/RHU.0b013e3181b0fe1e

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  3 in total

1.  Nodal and extranodal plasmacytomas expressing immunoglobulin a: an indolent lymphoproliferative disorder with a low risk of clinical progression.

Authors:  Haipeng Shao; Liqiang Xi; Mark Raffeld; Stefania Pittaluga; Kieron Dunleavy; Wyndham H Wilson; Nelson Spector; Cristiane Milito; Jose Carlos Morais; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2010-10       Impact factor: 6.394

2.  Non-lymphoma hematological malignancies in systemic lupus erythematosus.

Authors:  Mary Lu; Sasha Bernatsky; Rosalind Ramsey-Goldman; Michelle Petri; Susan Manzi; Murray B Urowitz; Dafna Gladman; Paul R Fortin; Ellen M Ginzler; Edward Yelin; Sang-Cheol Bae; Daniel J Wallace; Soren Jacobsen; Mary Anne Dooley; Christine A Peschken; Graciela S Alarcón; Ola Nived; Lena Gottesman; Lindsey A Criswell; Gunnar Sturfelt; Lene Dreyer; Jennifer L Lee; Ann E Clarke
Journal:  Oncology       Date:  2013-10-02       Impact factor: 2.935

Review 3.  Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance.

Authors:  Alexei Shimanovsky; Juliana Alvarez Argote; Shruti Murali; Constantin A Dasanu
Journal:  BBA Clin       Date:  2016-05-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.